Due to abnormal soluble guanylyl cyclase (sGC) expression and function, this pathological milieu may contribute to pulmonary arterial hypertension produced by pulmonary arterial vasoconstriction and remodeling. This evidence concerns the gene SGCB and pulmonary arterial hypertension.